YANGZHOU LIBERTY PHARMACEUTICAL CO LTD

Overview

YANGZHOU LIBERTY PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 25 active FDA Type II Drug Master Files, covering 9B, 11B-EPOXY-16A-METHYLPREGNA-1,4-DIENE-17,21-DIHYDROXY-3,20-DIONE; BEMPEDOIC ACID; BEMPEDOIC ACID (PROCESS II); BRIVARACETAM; CLASCOTERONE; DOXYCYCLINE HYCLATE.

API / Drug Master Files

YANGZHOU LIBERTY PHARMACEUTICAL CO LTD holds 25 active (26 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• VUTRISIRAN SODIUMActive2026-03-31
• ESTETROLActive2026-03-30
• VAMOROLONE ACETATEActive2026-03-30
• ESTRADIOL HEMIHYDRATEActive2026-03-30
• TIRZEPATIDEActive2025-12-31
• NUSINERSEN SODIUMActive2025-11-20
• SEMAGLUTIDEActive2025-09-26
• INCLISIRAN SODIUMActive2025-09-24
• DOXYCYCLINE HYCLATE (FOR USE IN THE MANUFACTURE OF PARENTERAL PREPARATIONS)Active2025-08-26
• BEMPEDOIC ACID (PROCESS II)Active2025-06-12
• RIMEGEPANT SULFATEActive2025-03-28
• CLASCOTERONEActive2024-12-11
• BRIVARACETAMActive2024-09-18
• VIBEGRONActive2024-07-14
• SEMAGLUTIDEActive2023-09-11

Showing 15 of 26 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to YANGZHOU LIBERTY PHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.